May 29,2007–Kelun Pharmaceutical, China’s largest producer of intravenous (IV) solution products, has entered into a definitive share purchase agreement to propose business combination with Shanghai Century Acquisition Corporation (Amex:SHA), a special purpose acquisition corporation.Kelun core corporate values are: ‘Seek truth through the application of science, observe ethics for the betterment of mankind’. The company focuses on the development and distribution of healthcare solutions, and its commercial development reflects the Chinese Government’s efforts to improve the nation’s health. We aim to create a brighter future for shareholders, employees, partners, stakeholders and society as a whole.